Why in the News?
Union Minister for Health and Family Welfare has launched the Annual Nationwide Mass Drug Administration (MDA) Campaign to eliminate Lymphatic Filariasis (LF).
About Lymphatic Filariasis (LF):
- Lymphatic Filariasis (LF), or “Hathi Paon”, is a mosquito-borne parasitic disease caused by Wuchereria bancrofti, Brugia malayi, and Brugia timori.
- It affects the lymphatic system, leading to swelling of limbs (lymphoedema) and scrotal swelling (hydrocele), causing permanent disability.
- LF spreads through repeated mosquito bites, making it a major public health challenge in tropical regions, including India.
- India aims to eliminate LF by 2027, ahead of the 2030 Sustainable Development Goal (SDG) target.
What is Mass Drug Administration (MDA)?
- MDA is a large-scale public health campaign where anti-filarial medicines are administered to all eligible individuals in endemic areas to stop LF transmission.
- Medication Regimens:
- Double Drug Therapy (DA): Diethylcarbamazine Citrate (DEC) + Albendazole
- Triple Drug Therapy (IDA): Ivermectin + DEC + Albendazole
- Key Features of MDA
- Door-to-door supervised drug administration ensures high coverage.
- Drugs are safe, free, and given twice a year in targeted districts.
- MDA is crucial for eliminating LF, as it reduces parasite transmission and protects millions from disability.
- EXCEPTIONS: Children below 2 years, pregnant women, and seriously ill individuals.
PYQ:[2017] Consider the following statements: 1. In tropical regions, Zika virus disease is transmitted by the same mosquito that transmits dengue. 2. Sexual transmission of Zika virus disease is possible. Which of the statements given above is/are correct? (a) 1 only (b) 2 only (c) Both 1 and 2 (d) Neither 1 nor 2 |
